Header Logo

Connection

ERIC JONASCH to Neoplasms, Hormone-Dependent

Back to Details
This is a "connection" page, showing publications ERIC JONASCH has written about Neoplasms, Hormone-Dependent.
ERIC JONASCH
Connection Strength
0.016
Neoplasms, Hormone-Dependent
  1. Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes. Cancer. 2006 May 15; 106(10):2143-7.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.